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Natural-dried ginseng is known as white ginseng, and red ginseng is made by steaming unpeeled white ginseng. As it is processed into red ginseng, white ginseng will lose malonyl groups (malonyl-Rb 1 , malonyl-Rb 2 , malonyl-Rc, and malonyl-Rd) and glycosyl groups at the C-20 position. Also, the hydroxyl group at the C-20 position can undergo isomerization and change into 20(S)-ginsenoside Rg 3 , 20(R)-ginsenoside Rh 2, and 20(R)-ginsenoside Rh 1 , which are characteristic components of red ginseng only [12] . When ginseng is taken, its protopanaxadiol-type ginsenosides will be changed into 20-O-D-glucopyranosyl-20(S)-protopanaxadiol (compound K) in the intestine by human intestinal bacteria [13] .
Various physiological and pharmacological effects of ginseng have been reported: general 'tonic', anti-fatigue, anti-stress, immune-modulator [14] [15] [16] , antioxidant, recovery from infl ammatory diseases, anti-aging, activation of brain function [17, 18] , improvement of mental performance [19] , anti-cancer [10, 20] , etc.
According to an epidemiologic study of a prospective cohort of 4,634 residents (over age 40) of major ginsengproducing area in Korea, the relative risk (RR) of cancer development for ginseng takers compared to non-takers was shown to be 0.48 (95% confidence interval, 0.34-0.67), and RR seemed to decrease as the frequency or duration of ginseng intake increased [9] . Also, ginseng takers are reported to have higher non organic-specific anti-carcinogenic effects than non-takers [21] . When 43 patients who required chemotherapy after stomach cancer surgery and 7 patients for whom surgery was impossible due to metastasis took red ginseng extract (3 g/ d) for 3 mo, red ginseng extract takers showed increased interleukin (IL)-2 content in the blood, while the content of decreased IL-10, a cytokine that suppresses anticancer immunity of the host, decreased, implying that red ginseng enabled recovery of immunity during anticancer chemotherapy [22] .
Red ginseng showed higher cytotoxicity against RAW264.7 than white ginseng, and tumor cell growth suppression was explained by the arrest of G 2 /M phase in the cell cycle [11] . Wang et al. [1] reported that the content of ginsenoside Rg 3 and ginsenoside Rh 2 was very low (0.06%) in unsteamed ginseng extract, however, after 4 h steaming, their content increased to 7.8% and 1.2%, respectively, and Rg 3 had a higher anti-cancer effect than Rh 2 .
Red ginseng and its extract have been reported to affect suppression of tumor angiogenesis, invasion, and metastasis [23] [24] [25] [26] . However, few studies to determine the underlying mechanism of suppression of tumor cell metastasis of red ginseng have been conducted.
In this study, we verifi ed a hypothesis that red ginseng can suppress metastasis of colon cancer cells by regulation of MMPs activity in vitro and in vivo.
MATERIALS AND METHODS

Materials and reagents
Red ginseng extract was provided from the Korea Ginseng Corporation (Seoul, Korea) which was manufactured from ginseng (P. ginseng). Red ginseng extract contained 0.519 mg/g ginsenoside Rg 1 and 4.028 mg/g ginsenoside Rb 1 . Red ginseng extract was diluted in cell culture medium for treatment. The following reagents and chemicals were obtained from the respective suppliers: Dulbecco's modifi ed Eagle's medium/Ham's F12 nutrient mixture (DMEM/F12) and streptomycin and penicillin were obtained from Gibco/BRL (Grand island, NY, USA). In addition, antibodies for MMPs were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). RIA-grade bovine serum albumin, transferrin, and other reagents were purchased from Sigma (St. Louis, MO, USA).
Cell culture
SW480 human colon cancer cells were purchased from the American Type Culture Collection (Rockville, MD, USA) and CT-26 mouse colon cancer cells were purchased from the Korean Cell Line Bank (Seoul, Korea). SW480 cells and CT-26 cells were maintained in DMEM/F12 containing 100 mL/L of fetal bovine serum (FBS) with 100,000 U/L of penicillin and 100 mg/L of streptomycin. The medium was replaced every 2-3 d For examination of red ginseng extract for cell proliferation, SW480 cells were plated in 24 well plates at a density of 2.5×10 4 cells/mL in DMEM/F12 supplemented with 10% FBS. Following 48 h incubation period, monolayers were serum-starved with DMEM/F12 supplemented with 5 μg/mL transferrin, 5 ng/mL selenium, and 1 mg/ mL bovine serum albumin for 24 h. Following serum starvation, monolayers were incubated in serum free medium (SFM) with 0, 100, 200, or 300 μg/mL red ginseng extract. Using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, viable cell numbers were estimated at 24, 48, and 96 h after exposure of cells to red ginseng extract, as previously described [27] . Experiments were performed independently three times.
Boyden chamber motility assay
The Boyden chamber motility assay was performed as previously described [28] . PVPF fi lters (8 μm diameter pore size) were coated with a 0.01% gelatin solution for 16 h at room temperature. SW480 cells (2×10 6 cell/mL), resuspended in SFM with or without 100 µg/L PMA in the absence or presence of various concentrations (100, 200, or 300 μg/mL) of red ginseng extract, were carefully transferred into the upper chambers. The lower chamber was fi lled with 10% FBS medium in order to attract the cells. The Boyden chamber was incubated at 37°C with 5% CO 2 for 16 h. After gentle removal of the fi lter from the chamber, cells on the upper chamber side of the fi lter were removed by wiping the fi lter with paper. The fi lter was stained with Diff-Quick stain solution (Dade Behring, Network, NJ, USA) and cells on the lower surface of the filter, were fixed onto a glass slide. Cells in five randomly selected microscopic fi elds (×400) of the lower slide were then counted. Experiments were performed independently three times.
Matrigel invasion assay
The Matrigel invasion assay was performed as previously described [28] . Wells of a Matrigel chamber (BD Bioscience, Bedford, MA, USA) were fi lled with SFM and adapted at room temperature. SW480 cells (1×10 6 cell/mL), resuspended in SFM with or without 100 µg/ L PMA in the absence or presence of various concentrations (100, 200, or 300 μg/mL) of red ginseng extract were carefully transferred into the upper chambers. The lower chambers were filled with 10% FBS medium in order to attract the cells. Matrigel chambers were incubated for 16 h at 37°C with 5% CO 2 . Cells on the upper surfaces of the fi lters were then removed by wiping the filter with paper. Filters were stained with Diff-Quick stain solution and cells on the lower surface of the fi lter were fi xed onto a glass slide. Cells in fi ve randomly selected microscopic fi elds (×400) of the lower slide were counted. Experiments were performed independently three times.
Matrix metalloproteinase activity (gelatin zymography)
MMP activity was investigated as previously described [29] . Cells were seeded into 6 well plates at density of 1×10 6 cells/mL and incubated in a medium containing 10% FBS for 48 h. Then, SW480 cells incubated in the absence or presence of various concentrations (100, 200 or 300 μg/mL) for 12 h. Supernatants were collected and concentrated 10-fold in Centricon centrifugal filter devices (Millipore, Bedford, MA, USA), after which MMP activity in the supernatants was investigated using gelatin zymography. Each supernatant was mixed with 2x sample buffer (Invitrogen, Carlsbad, CA, USA), and zymography was performed using gels (10% polyacrylamide, 1% gelatin). MMP activities were visualized by staining with Coomassie blue. Experiments were performed independently three times.
Western blotting analysis
MMP protein levels in the culture medium were determined by western blotting as previously described [28] . Conditioned media were collected and concentrated by the same procedures as that used for gelatin zymography. Proteins were separated by 4% to 20% gradient SDSpolyacrylamide gel electrophoresis and transferred to an immobilon TM -P transfer membrane (Millipore). The membrane was blocked in 5% milk/TBST (20 mmolL Tris-HCl, 137 mmol/L NaCl, and 0.1% Tween 20, pH 7.4) for 1 h at room temperature, incubated with monoclonal anti-MMP-2 and MMP-9 antibody/5% milk-TBST (1:200 dilution) for 3 h at room temperature, and washed for 30 min at room temperature in TBST. The membrane was then incubated with anti-mouse IgG horseradish peroxidase/5% milk-TBST (1:1,000 dilution, Amersham, Buckinghamshire, England). The presence of bound antibody was detected by chemiluminescence using Supersignal West Dura Extended Duration Substrate (Pierce, Rockford, IL, USA), and the intensity of the immunoreactive bands was quantifi ed using a densitometer (Sanyo, Tokyo, Japan). Experiments were performed independently three times.
Reverse transcriptase polymerase chain reaction
MMP mRNA levels in the culture medium were determined as previously described [29] . Total RNA was isolated using TRI-reagent (Sigma), and cDNA was synthesized using 2 μg of total RNA with SuperScript II reverse transcriptase (Invitrogen). For amplification of cDNA, primers for MMP-2 (upstream primer, 5'-CAG-GCTCTTCTCCTTTCSCAAC-3'; downstream primer, 5'-AAGCCACGGCTTGGTTTTCCTC-3') and MMP-9 (upstream primer, 5'-TGGGCTACGTGACCTATGAC-CAT-3'; downstream primer, 5'-GCCCAGCCCACCTC-CACTCCTC-3'; annealing at 55°C for 1 min with 35 cycles) were used. Polymerase chain reaction (PCR) products were separated on a 1% agarose gel and stained with ethidium bromide. Bands corresponding to each specific PCR product were quantified by densitometric scanning of the exposed fi lm using the Bio-profi le Bio-IL application (Vilber-Lourmat, Eberhardzell, Germany). 
Experimental metastasis
Experimental metastasis was performed as previously described [30] . Animals and diet: four-week-old male BALB/c mice were obtained from Daehan Biolink (Eumsung, Korea) and were initially fed a stock diet (Harlan Teklad Laboratory Animal Diets, Madison, WI, USA) for a 1-week adjustment period. Mice were randomly divided into fi ve groups. Experimental diets were based on the AIN-93G diet and red ginseng extract was administered orally. Animals were maintained according to animal care guidelines from the Dankook University ethics committee. They were housed in a temperaturecontrolled room (at 23±2°C) with light from 06:00 to 18:00 under specifi c pathogen-free conditions. Humidity was automatically maintained at 50±10%.
Lung metastasis: Mice were injected intravenously in the tail with CT-26 colon cancer cells suspended in SFM at a density of 5×10 5 cells/mL. Following injection, mice underwent oral administration of red ginseng extract each day at doses of 0, 75, 150, or 300 mg/kg BW for 3 wk, after which they were sacrifi ced and their lungs were removed. Lungs were stained with Bouin's solution and the numbers of metastatic colonies were counted.
Plasma MMP activity: 2 µL plasma was mixed with 2x sample buffer (Invitrogen), and zymography was performed using gels (10% polyacrylamide, 1% gelatin). MMP activities were visualized by staining with Coomassie blue. Experiments were performed independently three times.
Statistics
Statistical analyses were performed using SAS (SAS Institute, Cary, NC, USA). Data were expressed as means with standard deviations and analyzed via analysis of variance. Statistically signifi cant differences among the means of groups were tested at α=0.05 using Duncan›s multiple range test.
RESULTS
Korean red ginseng extract inhibits proliferation of SW480 cells
To examine the effects of red ginseng extract on SW480 colon cancer cell proliferation, cells in a monolayer culture were incubated in SFM with 0, 100, 200, or 300 μg/mL Korean red ginseng extract, and numbers of viable cells were estimated. Numbers of viable SW480 cells did not differ by red ginseng extract treatment from 0 to 300 μg/mL within 48 h. However, cell proliferation signifi cantly decreased following a 96 h incubation with the red ginseng extract at concentrations above 200 μg/ mL (Fig. 1) . In order to demonstrate that the anti-metastatic effect of red ginseng extract was independent of decreased cell proliferation, red ginseng extract treatment 4 cells/mL in Dulbecco's modified Eagle's medium/Ham's F12 nutrient mixture (DMEM/F12) supplemented with 10% fetal bovine serum. After 48 h incubation, the monolayers were serumstarved with DMEM/F12 supplemented with 5 μg/mL transferrin, 5 ng/mL selenium, and 1 mg/mL bovine serum albumin for 24 h. After serum starvation, the monolayers were incubated in serum-free medium with 0, 100, 200, or 300 μg/mL red ginseng extract. Viable cell numbers were estimated by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. Each bar represents the mean±SD calculated from three independent experiments. Comparisons among the different concentrations of red ginseng extract that yielded statistically signifi cant differences (p<0.05) are indicated by different letters above each bar. NS, not signifi cant. time in all experiments related to metastasis was never longer than 48 h in this study.
Korean red ginseng extract decreases the motility and invasion of SW480 cells
Cell migration plays an important role in the metastasis process. Because PMA has been shown to induce tumor cell migration/invasion [31, 32] , we examined the question of whether red ginseng extract is able to inhibit PMA-induced migration/invasion of SW480 cells. Using a Boyden chamber assay and a Matrigel invasion assay, red ginseng extract signifi cantly decreased PMA-induced motility (Fig. 2) (p<0.05) and PMA-induced invasion (Fig. 3) (p<0.05) .
Korean red ginseng extract reduces MMP-2 and MMP-9 activity in SW480 cells
The effects of red ginseng extract on MMP-2 and MMP-9 activity were tested. PMA has been known to increase MMP activity [33, 34] . Activity of MMP-2 and MMP-9 induced by PMA in SW480 cells was significantly reduced by red ginseng extract (Fig. 4) (p<0.05) .
Korean red ginseng extract inhibits protein and mRNA expressions of MMPs in SW480 cells
Protein expressions of MMP-2 and MMP-9 were assayed by western blot analysis. MMP-2 and MMP-9 protein expression in SW480 cells were induced by PMA, and which were signifi cantly decreased in a dosedependent manner (Fig. 5) (p<0.05) . We also performed RT-PCR analysis to determine the effects of red ginseng extract on MMP-2 and MMP-9 mRNA expression. As shown in Fig. 6 , PMA increased MMP-2 and MMP-9 mRNA expression, and red ginseng extract signifi cantly inhibited PMA-induced MMP-2 and MMP-9 mRNA expression in SW480 cells (p<0.05). Vol. 35, No. 3, 315-324 (2011) 
Korean red ginseng extract decreases experimental metastasis in BALB/c mice
Neither cancer cells injection nor red ginseng extract intake had an infl uence on weights of experimental animals (Table 1 ). Fig. 7 shows the effects of red ginseng extract on the number of colonies of CT-26 cells in the lungs. Red ginseng treatment signifi cantly decreased the number of colonies (p<0.05). Plasma MMP-2 and MMP-9 activity were significantly reduced in mice that were fed red ginseng extract (Fig. 8) (p<0.05) . 
DISCUSSION
Tumor metastasis is one of the most important causes of death of cancer patients. Therefore, research on natural materials with an anti-metastatic effect would be very meaningful. This study is the fi rst to show that red ginseng extract can suppress metastasis of colorectal cancer by inhibiting MMPs activity, both in vitro and in vivo.
In the present study, Korean red ginseng extract significantly decreased proliferation of SW480 cells after 96 h incubation. Wang et al. [1] reported that red ginseng extract increased pro-apoptotic gene expression (CASP5) and decreased anti-apoptotic gene expression (IGF1R) in SW480. Ginsenoside Rg 3 induced apoptosis by suppressing NF-κB expression in SW620 and HCT 116 colon cancer cells [35] , and LNCap, PC-3, and DU145 prostate colon cancer cells [36] . Also, ginsenoside Rd signifi cantly signifi cantly changed apoptosis-related proteins, such as Rho GDP dissociation inhibitor, Tropomyosin 1, and Annexin 5 in HT 29 cells [37] .
As mentioned above, Korean red ginseng extract suppressed tumor cell growth. However, in this study, in order to demonstrate that the anti-metastatic effect of the red ginseng extract is independent of suppression of tumor cell growth, we performed experiments related to metastasis under the condition that treatment time with the red ginseng extract did not last longer than 48 h. As a result, the red ginseng extract decreased PMA-induced mobility, invasion, and the activity, protein expression, and mRNA expression of MMPs of cancer cells, indicating that suppression of cancer metastasis by the red ginseng extract was independent of inhibition of tumor cell growth.
Tumor invasion is a key step in metastasis and includes tumor cell adhesion, migration, and enzymatic degradation of ECM and basement membrane [38] . Extracellular proteolysis is very important in cell migration and invasion, and is mediated by MMPs and serine proteinase [4, 5] . MMP is a zinc-dependent proteinase and can be classified by structure, substrate specificity, and position within the cell into collagenase, gelatinase, stromelysins, membrane-type MMP, and other MMPs [39] . MMP is secreted as an inactive pro-enzyme, and its activation is controlled by gene transcription, proenzyme activation, and suppression of tissue inhibitor of matrix metalloproteinase, etc. [40] . Vol. 35, No. 3, 315-324 (2011) Mochizuki et al. [23] reported that ginsenoside Rg 3 suppressed invasion of human lung carcinoma (OG10), pancreatic adenocarcinoma (PSN1), and B16-BL6 melanoma. Ginsenoside Rg 3 suppressed proliferation of human umbilical vein endothelial cells, formation of tube and invasion, activation of MMP-9 and MMP-2 in an aortic ring culture [41] , and expression of MMP-9 in a human ovarian cancer SKOV-3 cell line [42] .
PMA, a powerful tumor promoter, has been shown to induce tumor cell migration/invasion and increase MMPs activity [31] [32] [33] . Han et al. [34] showed that PMA increased MMP activity and affected invasion and motility properties of HM3 cells . PMA has been reported to regulate various cellular responses through the protein kinase C (PKC) pathway [43] , and PKC signaling pathways may be involved in regulation of invasion and metastatic properties of colon cancer cells [44, 45] . Therefore, it seems that the red ginseng extract suppresses motility/ invasion by inhibiting activation and gene expression of MMPs in SW480 cells via PKC pathway.
In the present study, oral intake of the red ginseng extract decreased the number of pulmonary nodules in experimental metastasis and the activity of MMP-2 and MMP-9 in plasma in a dose-dependent manner. Shibata reported that oral treatment with the ginsenoside Rg 3 at the concentrations of 2.5 or 5 mg/kg/d for 20 and 45 wk, suppressed cancer metastasis by 78% in Wistar rat [46] . Lung metastasis of B16-F10 mouse melanoma cells was suppressed in C57BL/6 mice that received ginsenoside Rp at a concentration of 3 mg/kg for 13 days [47] . Mochizuki et al. [23] reported on significantly decreased lung metastasis of B16-BL6 melanoma in rats that received injection (100 μg/mouse) or oral administration (100-1,000 μg/mouse) of ginsenoside Rg 3 . Matsuoka et al. [48] also reported that MMI-166, an inhibitor of MMPs, decreased liver metastasis in vivo, therefore, MMP should play a crucial role in cancer metastasis.
In conclusion, we have shown that Korean red ginseng extract can inhibit metastasis of SW480 colon cancer cells and that oral administration of red ginseng extract inhibits the metastasis of CT-26 cells to the lungs in a BALB/c murine model of experimentally induced cancer. We suggest that Korean red ginseng extract may contribute to metastasis inhibition by decreasing activity and expression of MMP-2 and MMP-9
